Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Open Badges Research news

How melanomas avoid apoptosis

William Wells

Genome Biology 2001, 2:spotlight-20010112-02  doi:10.1186/gb-spotlight-20010112-02

The electronic version of this article is the complete one and can be found online at:

Published:12 January 2001

© 2001 BioMed Central Ltd

Research news

Many cancers become resistant to chemotherapeutic drugs thanks to loss of the p53 protein, which promotes cell cycle arrest and apoptosis in response to certain drugs. Metastatic melanomas are unusual in that, despite their chemoresistance, they retain functional p53. In the January 11 Nature, Soengas et al. find that these melanomas still lose the p53 pathway thanks to deletion and methylation of the p53 effector Apaf-1 (Nature 2001, 409:207-211). The Apaf-1 locus shows over 40% loss of heterozygosity in melanomas, and in these cells the remaining Apaf-1 gene is no longer expressed. Expression and chemoresistance can be reactivated by addition of either a methylation inhibitor or a functional Apaf-1 gene.


  1. Malignant melanoma: modern black plague and genetic black box.

    PubMed Abstract | Publisher Full Text OpenURL

  2. [] webcite